Comments are Off
Innovative Technology, Jeune Entreprise Innovante, Young Innovative Enterprise
GENOSKIN has been labeled as a “Young Innovative Enterprise” by the French Ministry of Research for its innovative research program on in vitro skin models.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Shop – Europe & Middle-East
Shop – Asia & Pacific
Shop – United States & Canada
Genoskin CSO obtains high-profile career award
4 January 2022
Better Technology for Reliable Drug Development
3 January 2022
Genoskin launches spatial skin biology platform MANTIS®
6 December 2021
Dr. Nicolas Gaudenzio is appointed Chief Scientific Officer at Genoskin
8 November 2021